WallStreetZenWallStreetZen

NASDAQ: NPCE
Neuropace Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NPCE

Based on 1 analyst offering 12 month price targets for Neuropace Inc

Min Forecast
$20.00+23.92%
Avg Forecast
$20.00+23.92%
Max Forecast
$20.00+23.92%

Should I buy or sell NPCE stock?

Based on 1 analyst offering ratings for Neuropace Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NPCE's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates NPCE as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their NPCE stock forecasts and price targets.

NPCE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-15

1 of 1

Forecast return on equity

Is NPCE forecast to generate an efficient return?

Company
91.43%
Industry
17.46%
Market
174.26%
NPCE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NPCE forecast to generate an efficient return on assets?

Company
13.36%
Industry
14.28%
NPCE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NPCE earnings per share forecast

What is NPCE's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
-$0.62
Avg 2 year Forecast
-$0.31
Avg 3 year Forecast
-$0.07

NPCE revenue forecast

What is NPCE's revenue in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$102.0M+2.43%
Avg 2 year Forecast
$125.6M+26.22%
Avg 3 year Forecast
$156.3M+57%
NPCE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NPCE revenue growth forecast

How is NPCE forecast to perform vs Medical Devices companies and vs the US market?

Company
15.84%
Industry
8.54%
Market
13.95%
NPCE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NPCE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NPCE vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
NPCE$16.14$20.00+23.92%Buy
CLPT$18.72$25.00+33.55%Strong Buy
PACB$1.68$1.50-10.71%Strong Sell
KIDS$19.95$24.25+21.55%Strong Buy
CTKB$4.59$5.08+10.74%Strong Buy
View Top Medical Device Stocks

Neuropace Stock Forecast FAQ

Is Neuropace Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NPCE) stock is to Buy NPCE stock.

Out of 1 analyst, 0 (0%) are recommending NPCE as a Strong Buy, 1 (100%) are recommending NPCE as a Buy, 0 (0%) are recommending NPCE as a Hold, 0 (0%) are recommending NPCE as a Sell, and 0 (0%) are recommending NPCE as a Strong Sell.

If you're new to stock investing, here's how to buy Neuropace stock.

What is NPCE's earnings growth forecast for 2026-2028?

(NASDAQ: NPCE) Neuropace's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.79%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.17%.

Neuropace's earnings in 2026 is -$21,565,000.On average, 10 Wall Street analysts forecast NPCE's earnings for 2026 to be -$21,114,256, with the lowest NPCE earnings forecast at -$25,393,021, and the highest NPCE earnings forecast at -$12,887,436. On average, 10 Wall Street analysts forecast NPCE's earnings for 2027 to be -$10,483,827, with the lowest NPCE earnings forecast at -$22,720,072, and the highest NPCE earnings forecast at $3,579,843.

In 2028, NPCE is forecast to generate -$2,434,293 in earnings, with the lowest earnings forecast at -$19,044,766 and the highest earnings forecast at $8,233,639.

What is NPCE's revenue growth forecast for 2026-2028?

(NASDAQ: NPCE) Neuropace's forecast annual revenue growth rate of 15.84% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.95%.

Neuropace's revenue in 2026 is $99,530,000.On average, 10 Wall Street analysts forecast NPCE's revenue for 2026 to be $3,475,857,303, with the lowest NPCE revenue forecast at $3,307,775,140, and the highest NPCE revenue forecast at $3,601,322,284. On average, 10 Wall Street analysts forecast NPCE's revenue for 2027 to be $4,283,197,184, with the lowest NPCE revenue forecast at $3,862,480,371, and the highest NPCE revenue forecast at $4,570,607,455.

In 2028, NPCE is forecast to generate $5,327,488,594 in revenue, with the lowest revenue forecast at $4,874,723,660 and the highest revenue forecast at $5,727,749,160.

What is NPCE's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: NPCE) forecast ROA is 13.36%, which is lower than the forecast US Medical Devices industry average of 14.28%.

What is NPCE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NPCE price target, the average NPCE price target is $20.00, with the highest NPCE stock price forecast at $20.00 and the lowest NPCE stock price forecast at $20.00.

The Wall Street analyst predicted that Neuropace's share price could reach $20.00 by May 15, 2027. The average Neuropace stock price prediction forecasts a potential upside of 23.92% from the current NPCE share price of $16.14.

What is NPCE's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: NPCE) Neuropace's current Earnings Per Share (EPS) is -$0.65. On average, analysts forecast that NPCE's EPS will be -$0.62 for 2026, with the lowest EPS forecast at -$0.74, and the highest EPS forecast at -$0.38. On average, analysts forecast that NPCE's EPS will be -$0.31 for 2027, with the lowest EPS forecast at -$0.67, and the highest EPS forecast at $0.11. In 2028, NPCE's EPS is forecast to hit -$0.07 (min: -$0.56, max: $0.24).

What is NPCE's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: NPCE) forecast ROE is 91.43%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.